Salem Hesham, Madian Hoda, Emad Soheir, Hussien Maha, Mazen Dina Z
Pharmaceutical chemistry department, faculty of pharmacy, Deraya University, New Minia, Egypt.
Faculty of pharmacy, Deraya University, New Minia, Egypt.
J Fluoresc. 2025 May;35(5):3557-3563. doi: 10.1007/s10895-024-03767-w. Epub 2024 Jun 12.
Pemetrexed is a chemotherapeutic medicine, under the trade name Alimta. Malignant pleural mesothelioma patients. Its application in lung cancer has been studied. Here in, a second spectrofluorimetric method was advanced for quantifying of Pemetrexed in pharmaceutical formulation and spiked human plasma. That method depends on fluorescence derivatization of Pemetrexed with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) at 75 °C in a (pH 9) of borate buffer to produce a fluorescent derivative which can be detected at 520 nm afterwards excitation at 460 nm. The method has been validated using ICH criteria, and it demonstrated linearity in a range of 2-120 ngmL-1. The proposed method was applied precisely and accurately for quantifying Pemetrexed within pharmaceutical formulation and spiking human plasma without any interferences. Moreover, the method's sustainability was evaluated and compared to the published method using two greenness assessment tools termed analytical eco-scale and Analytical GREENness (AGREE). That findings suggest that the method is more sustainable than the published method.
培美曲塞是一种化疗药物,商品名为力比泰。用于恶性胸膜间皮瘤患者。其在肺癌中的应用已得到研究。在此,提出了第二种荧光分光光度法,用于定量药物制剂和加标人血浆中的培美曲塞。该方法基于培美曲塞在75°C、pH 9的硼酸盐缓冲液中与4-氯-7-硝基苯并-2-恶唑-1,3-二氮杂茂(NBD-Cl)进行荧光衍生化反应,生成一种荧光衍生物,在460nm激发后可在520nm处检测到。该方法已按照国际协调会议(ICH)标准进行验证,在2-120 ngmL-1范围内呈线性。所提出的方法可精确、准确地定量药物制剂和加标人血浆中的培美曲塞,且无任何干扰。此外,使用称为分析生态尺度和分析绿色度(AGREE)的两种绿色度评估工具对该方法的可持续性进行了评估,并与已发表的方法进行了比较。结果表明,该方法比已发表的方法更具可持续性。